Huatai PeptideRetatrutide
Ordered Retatrutide from Huatai Peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyHuatai Peptide's Retatrutide profile is driven by repeated purity misses after a lone clean result, not by identity failures. The sharpest details are a 97.64% purity result and one 20 mg vial testing at 12.5 mg, with uneven batch records.
Domain and certificate records put Huatai's storefront much younger than its long-history marketing, with sister-domain and Hostinger staging artifacts muddying the operator trail. The report also tracks copied QC content, unresolved COA verification, and crypto/Wise recourse risk.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Huatai Peptide rows.
Cancel anytime
About Huatai Peptide test results from Finnrick
Huatai Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 12 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Huatai Peptide peptides in this dataset are Retatrutide (10 tests), Tirzepatide (2 tests) and Tesamorelin (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 12 recent tests.
Ordered Retatrutide from Huatai Peptide? Mail in a sample (US only) and let us test it for free.
Test my supply